Centre de radiothérapie de Ris Orangis - CRRO - Almaviva Santé

What Centre de radiothérapie de Ris Orangis - CRRO - Almaviva Santé does

Centre de radiothérapie de Ris Orangis (CRRO) is a French private radiotherapy clinic located in Ris-Orangis, Île-de-France, operating as a SAS (société par actions simplifiée) with €1,500,000 in share capital and approximately 12 employees. It is part of the Almaviva Santé private hospital group. The center treats approximately 1,500 cancer patients per year through roughly 25,000 radiotherapy sessions, drawing on a fleet of five particle accelerators that includes a CyberKnife robotic radiosurgery system and a TrueBeam STX linear accelerator installed in 2019.

CRRO's clinical proposition is precision external-beam radiotherapy, including conventional fractionated radiotherapy and stereotactic radiosurgery via CyberKnife, delivered under ASN (Autorité de Sûreté Nucléaire) and ARS (Agence Régionale de Santé) authorizations. It is physically co-located with Clinique Pasteur, forming the Essonne Cancer Centre, a multidisciplinary hub integrating radiotherapy with surgical and medical oncology pathways. The center is a member of the 3C Centre de Coordination en Cancérologie du Sud Ile-de-France, embedding it in the regional cancer-care coordination governance structure.

The business model is fee-for-service radiotherapy reimbursed through the French Sécurité Sociale and complementary health mutuelles under regulated national tariff schedules. Patient acquisition is driven by oncologist referrals, regional hospital partnerships, digital booking via Doctolib, and community-facing cancer-screening awareness campaigns (Octobre Rose, Mars Bleu, Juin Vert). As a private clinic within the Almaviva Santé group, CRRO benefits from shared back-office, procurement, and capital-allocation functions of the parent operator.

Name

Centre de radiothérapie de Ris Orangis - CRRO - Almaviva Santé

Legal name

CENTRE DE RADIOTHERAPIE DE RIS ORANGIS

Website

https://radiotherapie-risorangis.fr

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

CRRO is a private radiotherapy center in Ris-Orangis, Île-de-France, part of Almaviva Santé, operating five particle accelerators (including CyberKnife) to treat approximately 1,500 cancer patients across 25,000 sessions annually, reimbursed through the French Sécurité Sociale.

Ownership category

akta.pro rank

Product category

Radiation Oncology / Cancer Treatment Services

NAICS

Diagnostic Imaging Centers (621512)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Radiotherapy treatment
• Cancer care services
• Stereotactic radiosurgery
• Oncology centre
• Radiation oncology

Headquarters

HQ city

Ris-Orangis

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Radiotherapy Treatment Services: The centre generates revenue through providing radiotherapy treatment services to cancer patients. Services are covered by French social security (Sécurité Sociale) and complementary health insurance. The centre operates within the French healthcare reimbursement system.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

The Centre de Radiothérapie de Ris-Orangis (CRRO) provides external radiotherapy, combined radio-chemotherapy and stereotactic radiotherapy (intra- and extra-cranial) to adult cancer patients using five particle accelerators (CyberKnife, TrueBeam STX, two Clinac 2100 and a UNIQUE Performance system) together with a dedicated radiotherapy planning CT scanner. It is part of the Essonne Cancer Centre with the chemotherapy day hospital of Clinique Pasteur on the same site and operates within the French Sécurité Sociale reimbursement framework.

Product overview

The Centre de Radiothérapie de Ris-Orangis (CRRO) is a specialized radiotherapy center that provides cancer treatment services. The center operates as a unified healthcare service offering radiotherapy treatments through five particle accelerators and associated imaging/planning equipment. The facility includes a SOMATOM AS 20 Siemens radiotherapy scanner for treatment preparation, and the technical platform consists of CYBERKNIFE, TRUEBEAM STX, CLINAC 2100, CLINAC 2100 IX, and UNIQUE Performance systems. Patients receive treatment through a structured process involving preparation scanning, positioning verification, and treatment sessions, with consultations provided by radiotherapists throughout the care pathway.

Differentiator

Problem solved

Functional benefit

Products and services

• External Radiotherapy Treatment External beam radiotherapy delivered to adult cancer patients using particle accelerators (CyberKnife, TrueBeam STX, Clinac 2100, UNIQUE Performance), with treatment preparation on a Siemens Somatom AS 20 CT scanner. Indicated for breast, prostate, lung, brain, colorectal, cervical and other adult cancers.
• Stereotactic Radiotherapy (intra- and extra-cranial) High-precision stereotactic radiotherapy/radiosurgery for intra- and extra-cranial lesions, using the CyberKnife robotic platform and TrueBeam STX with advanced imaging and specialised immobilisation equipment. Targets adult cancer patients requiring precision radiosurgery.
• Combined Radio-Chemotherapy Combined radiotherapy and chemotherapy treatment for adult cancer patients, delivered through coordination with the chemotherapy day hospital of Clinique Pasteur on the same site as the Essonne Cancer Centre.
• Palliative Radiotherapy Palliative radiotherapy for adult cancer patients aimed at symptom control and quality of life, delivered using the centre's particle accelerator fleet.
• Radiotherapist Consultations Specialist consultations with radiotherapists as part of the patient care pathway, including treatment planning and follow-up visits for adult cancer patients.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Clinique PasteurcoreStrategic or Co-development PartnerLocated on the same site as Clinique Pasteur, forming the Essonne Cancer Centre (Pôle de Cancérologie en Essonne) with the chemotherapy day hospital. Provides integrated cancer care services.
• SofcotminorOthersPartnership with Sofcot (French society for orthopedic surgery/orthopedic oncology) for collaboration in cancer treatment.
• FHPminorOthersMember of FHP (Fédération de l'Hospitalisation Privée - French Private Hospital Federation).
• HASminorOthersAffiliated with HAS (Haute Autorité de Santé - French High Authority for Health) for quality standards and accreditation.
• INCAminorOthersAffiliated with INCA (Institut National du Cancer - French National Cancer Institute) for cancer treatment standards and accreditation criteria.
• C2DSminorOthersMember of C2DS (Comité pour le Développement Durable en Santé) for sustainable development in healthcare.
• 3C Centre de Coordination en Cancérologie du Sud Ile-de-FrancecoreStrategic or Co-development PartnerThe CRRO is a member of the 3C coordination centre for cancer care in South Ile-de-France, coordinating multidisciplinary consultation meetings and cancer care pathways.
• Scope SantéminorOthersListed on Scope Santé platform for healthcare quality transparency and public information.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Others

• Varian (Siemens Healthineers): Manufacturer of the TrueBeam, UNIQUE and CLINAC linac platforms installed at CRRO. Comparable as an enabling ecosystem player whose product roadmap directly shapes CRRO's clinical capability, upgrade path, and replacement-capex exposure.
• Elekta: Competing radiotherapy equipment manufacturer (linacs, Gamma Knife, brachytherapy). Comparable as an adjacent technology vendor shaping the broader competitive landscape for radiotherapy equipment that CRRO must benchmark against for procurement and clinical positioning.
• Accuray: Manufacturer of the CyberKnife robotic radiosurgery system in operation at CRRO. Comparable as an enabling technology vendor whose service support, software updates, and lifecycle policies materially affect CRRO's stereotactic-radiotherapy service line.

Broad incumbents

• Centre Léon Bérard: CLCC comprehensive cancer center in Lyon providing radiotherapy, chemotherapy and supportive care. Comparable as a regional French radiation-oncology provider within the same INCA-accredited framework, though operating at larger scale and broader scope.
• GenesisCare: International cancer-care operator running radiotherapy centers across Europe and Australia with similar stereotactic/advanced-radiotherapy offerings. Comparable as a private-sector, technology-led radiation-oncology provider, but at significantly larger geographic scale than CRRO.
• Institut de Cancérologie de l'Ouest (ICO): Western France CLCC network (Nantes, Angers, Saint-Herblain) offering radiotherapy and comprehensive oncology services. Comparable as a regionally anchored French radiation-oncology platform under the same national accreditation regime as CRRO.
• Gustave Roussy: Leading European cancer center in Villejuif offering radiotherapy within a full oncology portfolio. Comparable as a high-end French radiotherapy provider serving complex cases, but with significantly broader clinical, research, and inpatient capabilities than CRRO.
• Institut Curie: Paris-based comprehensive cancer center operating radiotherapy, chemotherapy and research platforms. Comparable as a leading French radiation-oncology provider, but operates at much broader scale with academic/research mission beyond CRRO's regional ambulatory focus.
• American Hospital of Paris: Private not-for-profit hospital in Neuilly-sur-Seine offering oncology services including radiotherapy. Comparable as a French private-sector cancer/radiotherapy provider in the Paris region with overlapping patient catchment, though with broader acute-care positioning.
• Centre François Baclesse: CLCC comprehensive cancer center in Caen providing radiotherapy and oncology services. Comparable as a French regional radiation-oncology provider operating under identical INCA/ARS regulatory framework, but at broader academic and inpatient scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/centre-de-radioth%C3%A9rapie-de-ris-orangis

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre de radiothérapie de Ris Orangis - CRRO - Almaviva Santé